Coldstream Capital Management’s Halozyme HALO Stock Holding History

Coldstream Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$573K	Sell	8,863 -8	-0.1%	-$564	0.01%	673
2025 Q4	$597K	Sell	8,871 -43	-0.5%	-$2.89K	0.01%	646
2025 Q3	$654K	Buy	8,914 +165	+2%	+$11K	0.01%	622
2025 Q2	$455K	Sell	8,749 -425	-5%	-$24.2K	0.01%	700
2025 Q1	$585K	Buy	9,174 +121	+1%	+$7.03K	0.01%	543
2024 Q4	$433K	Sell	9,053 -198	-2%	-$10.2K	0.01%	666
2024 Q3	$534K	Buy	9,251 +2,384	+35%	+$137K	0.01%	589
2024 Q2	$360K	Buy	6,867 +124	+2%	+$5.44K	0.01%	693
2024 Q1	$274K	Sell	6,743 -178	-3%	-$6.67K	0.01%	802
2023 Q4	$256K	Buy	+6,921	New	+$261K	0.01%	773
2023 Q1	–	Sell	-4,930	Closed	-$281K	–	846
2022 Q4	$281K	Buy	+4,930	New	+$252K	0.01%	631
2022 Q2	$200K	Buy	+4,562	New	+$197K	0.01%	735

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Coldstream Capital Management's HALO Position: Q1 2026 in Review

Coldstream Capital Management reduced its Halozyme (HALO) stake by 0.09% in Q1 2026, selling an estimated $564 and leaving 8,863 shares worth $573K. The position accounts for 0.01% of the portfolio, ranked #673.

Coldstream Capital Management first reported a position in HALO in Q2 2022 and has held it in 12 quarters since. The position peaked at $654K in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Coldstream Capital Management held 8,863 shares of Halozyme worth $573K as of Q1 2026.
Coldstream Capital Management sold 8 Halozyme shares in Q1 2026, an estimated $564.
Halozyme made up 0.01% of Coldstream Capital Management's portfolio in Q1 2026, its #673 holding.
Coldstream Capital Management first reported a position in Halozyme in Q2 2022 and has held it in 12 quarters since.
Coldstream Capital Management's Halozyme position peaked at $654K in Q3 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Coldstream Capital Management's 13F filing for Q1 2026, filed 8 May 2026.